Vedanta Makes Two New Appointments
This article was originally published in Scrip
Vedanta Biosciences has appointed Lisa Rae Schopf head of preclinical development and Erick J. Spek head of intellectual property. Schopf joins Vedanta from Kala Pharmaceuticals where she was senior director of preclinical development and has also previously worked at Virdante Pharmaceuticals, Abbott Bioresearch Centre, Millennium and Genetics Institute. Prior to joining Vedanta, Spek was director of IP at Epizyme, Inc. and before this he worked at Wolf Greenfield, an IP law firm.